Jeffrey A. Bailey

Jeffrey A. Bailey joined our Board of Directors as an independent director in March 2020. Mr. Bailey currently serves as Chairman of Aileron Therapeutics since March 2018 and as a Board Member of Madison Vaccines, a privately held biopharmaceutical company, since October 2017. Since January 2018, Mr. Bailey has served as Chief Executive Officer and Director of IlluminOss Medical, Inc. Previously, Mr. Bailey served as Chair and Chief Executive Officer of Neurovance, Inc., a biotechnology firm acquired by Otsuka Pharmaceutical in 2017. Prior to that, Mr. Bailey served as President and Chief Executive Officer and as a Director of Lantheus Medical Imaging, Inc., a public medical diagnostic company. Mr. Bailey holds diverse leadership experiences in commercial and supply chain management from various positions with several public and private pharmaceutical and medical device companies, including Operating Unit President at Novartis Pharmaceuticals, and a 22-year career with Johnson & Johnson / Janssen Pharmaceutica NV. Mr. Bailey received a B.S. from Rutgers University.